| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:1533.)
© 2005 American Heart Association, Inc.
Original Contributions |
From The Center for Cerebrovascular Research, Departments of Anesthesia (Y.Z., C.L., F.S., W.L.Y., G.-Y.Y.), Neurological Surgery (R.D., W.L.Y., G.-Y.Y.), and Neurology (W.L.Y.), University of California, San Francisco, Calif; Department of Neurosurgery (Y.Z., G.-Y.Y.), Hua-Shan Hospital, Fu-Dan University, Shanghai, China.
Correspondence to Guo-Yuan Yang, MD, PhD, Department of Anesthesia, CCR, UCSFGH, Box1371, 1001 Potrero Ave, San Francisco, CA 94110. E-mail gyyang{at}anesthesia.ucsf.edu
Background and Purpose A better understanding of angiogenic factors and their effects on cerebral angiogenesis is necessary for the development of effective therapeutic strategies for ischemic brain injury. Vascular endothelial growth factor (VEGF) has been shown to induce angiogenesis in the adult mouse brain. However, the function of angiopoietin-2 (Ang-2) in cerebral angiogenesis has not been clarified. The goal of this study was to identify the combined effects of VEGF and Ang-2 on cerebral angiogenesis and the bloodbrain barrier (BBB).
Methods Six groups of 6 adult male CD-1 mice underwent AdlacZ (viral vector control), AdVEGF, AdAng2, VEGF protein, VEGF protein plus AdAng2, or saline (negative control) injection. Microvessels were counted using lectin staining on tissue sections after 2 weeks of treatment. Matrix metalloproteinase-9 (MMP-9) activity was determined by zymography. The presence of zonula occludens-1 (ZO-1) protein was determined by Western blot and immunohistochemistry.
Results Mice treated with VEGF protein infusion plus AdAng-2 significantly increased microvessel counts relative to all other groups (P<0.05). The changes in MMP-9 activity paralleled the reduced ZO-1 expression in the VEGF plus Ang-2treated group compared with the other 5 groups (P<0.05). Double-labeled immunostaining demonstrated that ZO-1positive staining was significantly decreased on the microvessel wall in the VEGF plus Ang-2treated group.
Conclusions Our study demonstrates that the combination of VEGF and Ang-2 promotes more angiogenesis compared with VEGF alone. Furthermore, the combination of VEGF and Ang-2 may lead to BBB disruption because it increases MMP-9 activity and inhibits ZO-1 expression.
Key Words: angiogenesis bloodbrain barrier
This article has been cited by other articles:
![]() |
A. M Abu El-Asrar, L. Missotten, and K. Geboes Expression of hypoxia-inducible factor-1{alpha} and the protein products of its target genes in diabetic fibrovascular epiretinal membranes Br. J. Ophthalmol., June 1, 2007; 91(6): 822 - 826. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |